AACR Panel: Small Studies Can Yield Cancer Treatment Insights | GenomeWeb

WASHINGTON (GenomeWeb News) – Small studies, sometimes containing a single patient, can be applied to unravel the biological mechanisms behind cancer drug response as well as identify possible drug treatments for a specific cancer type, according to researchers.

While such small studies may be dismissed by some as anecdotes, panelists at an afternoon session yesterday at the American Association for Cancer Research annual meeting here argued that such studies can be used to resurrect abandoned drugs and to reveal known drugs to which a tumor may be susceptible.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.